ArticleCardio-oncology (London, England)2026
Interpretable machine learning for cardiovascular disease risk prediction in cancer survivors: development and internal validation.
Guoxing Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.